Use of cardiotrophin-1 for the treatment of metabolic diseases

Details Use of cardiotrophin-1 for the treatment of metabolic diseases Use of cardiotrophin-1 for the treatment of metabolic diseases

A - Human Necessities

61

K

A61K 38/19 (2006.01) A61P 3/00 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2750074

The invention is related to the use of cardiotrophin-1 (CT-1) for the treatment of obesity and associated disorders: hyperglycaemias, insulin resistance, development of type 2 diabetes and dyslipemias and given its anorexigenic role, fat oxidation stimulant, hypoglycaemic, sensitizing agent of the action of insulin on a skeletal muscle level and inhibitor of the intestinal transport of glucose by enterocytes.

L'invention concerne l'utilisation de la cardiotrophine-1 (CT-1) pour le traitement de l'obésité et de maladies associées : hyperglycémies, insulinorésistance, développement du diabète de type 2 et dyslipidémies; et son utilisation en raison de son rôle anorexigène, stimulateur de l'oxydation des graisses, hypoglycémiant, et renforçateur de l'action de l'insuline au niveau du muscle squelettique et inhibiteur du transport intestinal du glucose par les entérocytes.

Affiliated with

Also associated with

Rating

Use of cardiotrophin-1 for the treatment of metabolic diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of cardiotrophin-1 for the treatment of metabolic diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cardiotrophin-1 for the treatment of metabolic diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2018036